Detailed Information on Publication Record
2016
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-beta-Catenin Signaling in Colorectal Cancer
OHTSUKA, Masahisa, Hui LING, Cristina IVAN, Martin PICHLER, Daisuke MATSUSHITA et. al.Basic information
Original name
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-beta-Catenin Signaling in Colorectal Cancer
Authors
OHTSUKA, Masahisa (840 United States of America), Hui LING (840 United States of America), Cristina IVAN (840 United States of America), Martin PICHLER (840 United States of America), Daisuke MATSUSHITA (840 United States of America), Matthew GOBLIRSCH (840 United States of America), Verena STIEGELBAUER (40 Austria), Kunitoshi SHIGEYASU (840 United States of America), Xinna ZHANG (840 United States of America), Meng CHEN (840 United States of America), Fnu VIDHU (840 United States of America), Geoffrey A. BARTHOLOMEUSZ (840 United States of America), Yuji TOIYAMA (392 Japan), Masato KUSUNOKI (392 Japan), Yuichiro DOKI (392 Japan), Masaki MORI (392 Japan), Shumei SONG (840 United States of America), Jillian R. GUNTHER (840 United States of America), Sunil KRISHNAN (840 United States of America), Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution), Ajay GOEL (840 United States of America), Jaffer A. AJANI (840 United States of America), Milan RADOVICH (840 United States of America) and George A. CALIN (840 United States of America)
Edition
EBioMedicine, Amsterdam, Elsevier Science BV, 2016, 2352-3964
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14740/16:00093867
Organization unit
Central European Institute of Technology
UT WoS
000390704800027
Keywords in English
H19; RB1; E2F; CDK8; beta-Catenin; Colorectal cancer
Tags
Změněno: 10/3/2017 09:28, Mgr. Eva Špillingová
Abstract
V originále
The clinical significance of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC) remains largely unexplored. Here, we analyzed a large panel of lncRNA candidates with The Cancer Genome Atlas (TCGA) CRC dataset, and identified H19 as the most significant lncRNA associated with CRC patient survival. We further validated such association in two independent CRC cohorts. H19 silencing blocked G1-S transition, reduced cell proliferation, and inhibited cell migration. We profiled gene expression changes to gain mechanism insight of H19 function. Transcriptome data analysis revealed not only previously identified mechanisms such as Let-7 regulation by H19, but also RB1-E2F1 function and beta-catenin activity as essential upstream regulators mediating H19 function. Our experimental data showed that H19 affects phosphorylation of RB1 protein by regulating gene expression of CDK4 and CCND1. We further demonstrated that reduced CDK8 expression underlies changes of beta-catenin activity, and identified that H19 interacts with macroH2A, an essential regulator of CDK8 gene transcription. However, the relevance of H19-macroH2A interaction in CDK8 regulation remains to be experimentally determined. We further explored the clinical relevance of above mechanisms in clinical samples, and showed that combined analysis of H19 with its targets improved prognostic value of H19 in CRC. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Links
LQ1601, research and development project |
|